TBX21, T-box transcription factor 21, 30009

N. diseases: 124; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease GWASCAT Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct. 30929738 2019
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Among the genes identified, variants in T-box 21 ( TBX21) and Fc fragment of IgE receptor II ( FCER2) contribute indirectly to the variability in the response to ICS by altering the inflammatory mechanisms in asthma, while other genes such as corticotropin releasing hormone receptor 1 ( CRHR1), nuclear receptor subfamily 3 group C member 1 ( NR3C1), stress induced phosphoprotein 1 ( STIP1), dual specificity phosphatase 1 (DUSP1), glucocorticoid induced 1 (GLCCI1), histone deacetylase 1 (HDAC), ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3), and vascular endothelial growth factors (VEGF) directly affect this variability through the anti-inflammatory mechanisms of ICS. 29251255 2017
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Eighty-two children (56 boys/26 girls, mean age 9.6 ± 3.2 years) with moderate-severe asthma exacerbation were genotyped for eight single-nucleotide polymorphisms that were a priori associated with ICS response in chronic asthma treatment: glucocorticosteroid receptor (NR3C1) rs41423247; corticotrophin-releasing hormone receptor1 (CRHR1) rs242939, rs242941, and rs1876828; T-box 21 (TBX21) rs2240017; glucocorticoid-induced transcript 1 (GLCCl1); and T gene rs3099266 and rs2305089. 27003716 2016
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Furthermore, haplotypes TG (OR=2.83; P=0.001) and TA (OR=2.54; P=0.001) of TBX21 were associated with an increased risk of asthma. 25056814 2014
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Polymorphisms in TBX21, a gene important for the biological action of corticosteroids, could be associated with treatment response in asthmatics. 24107858 2013
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE This study investigated the influence of TBX21 and HLX1 single nucleotide polymorphisms (SNPs), which have previously been shown to be associated with asthma, on T(H)1/T(H)2 lineage cytokines at birth. 22303482 2012
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Of the four genetic polymorphisms examined, NK2R G231E G>A and TBX21 H33Q C>G were significantly associated with asthma control status (P = 0.041 and P = 0.006). 20175803 2009
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Furthermore, the impact of combinations of TBX21 and HLX1 polymorphisms on the development of asthma was assessed by using a risk score model. 19362357 2009
CUI: C0004096
Disease: Asthma
Asthma
0.700 Biomarker disease BEFREE An association between a specific TBX21 haplotype and allergic asthma in children is demonstrated for the first time and might explain previously detected associations between SNPs within TBX21 and asthma and bronchial hyperresponsiveness. 17949803 2008
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease LHGDN An association between a specific TBX21 haplotype and allergic asthma in children is demonstrated for the first time and might explain previously detected associations between SNPs within TBX21 and asthma and bronchial hyperresponsiveness. 17949803 2008
CUI: C0004096
Disease: Asthma
Asthma
0.700 AlteredExpression disease BEFREE In conclusion, (1) p38MAPK-pathway rather than ERK-pathway may play a more basic role in the regulation of the increased T-bet expression in asthma, and (2) ERK- and p38MAPK-activation modulate IFNgamma expression independently of T-bet and this regulatory role of ERK-1/-2 on IFNgamma release is impaired in asthma. 17127048 2007
CUI: C0004096
Disease: Asthma
Asthma
0.700 AlteredExpression disease BEFREE AM could increase the expression of T-bet mRNA and Thl cytokines such as IFN-Y, and might reverse the Th2 predominant status in asthma patients. 17361521 2006
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease LHGDN T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. 16179640 2006
CUI: C0004096
Disease: Asthma
Asthma
0.700 Biomarker disease CTD_human In order to examine whether polymorphisms in the candidate gene, TBX21, located on chromosome 17q21.32, are related to the risk of human asthma phenotypes, we have searched for genetic variations in the human TBX21 gene and identified 24 single nucleotide polymorphisms (SNPs), including five novel SNPs, by direct sequencing in Japanese subjects. 15806396 2005
CUI: C0004096
Disease: Asthma
Asthma
0.700 Biomarker disease BEFREE Mice lacking the T-bet gene (tbx21) demonstrate multiple physiological and inflammatory features reminiscent of human asthma. 15806396 2005
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease LHGDN In order to examine whether polymorphisms in the candidate gene, TBX21, located on chromosome 17q21.32, are related to the risk of human asthma phenotypes, we have searched for genetic variations in the human TBX21 gene and identified 24 single nucleotide polymorphisms (SNPs), including five novel SNPs, by direct sequencing in Japanese subjects. 15806396 2005
CUI: C0004096
Disease: Asthma
Asthma
0.700 AlteredExpression disease BEFREE Within the Finnish asthmatic founder population, there was no association between T-bet SNPs and high serum IgE level or asthma. 15248849 2004
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease LHGDN TBX21 may thus be an important determinant pharmacogenetic response to the therapy of asthma with inhaled corticosteroids. 15604153 2004
CUI: C0004096
Disease: Asthma
Asthma
0.700 Biomarker disease BEFREE TBX21 may thus be an important determinant pharmacogenetic response to the therapy of asthma with inhaled corticosteroids. 15604153 2004
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Using statistical analyses for association of TBX21 polymorphisms with these three asthma phenotypes, no significant signals were detected. 12938094 2003
CUI: C0004096
Disease: Asthma
Asthma
0.700 Biomarker disease MGD Mice with a targeted deletion of the T-bet gene and severe combined immunodeficient mice receiving CD4+ cells from T-bet knockout mice spontaneously demonstrated multiple physiological and inflammatory features characteristic of asthma. 11786643 2002
CUI: C0004096
Disease: Asthma
Asthma
0.700 Biomarker disease MGD Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. 11786644 2002
CUI: C0004096
Disease: Asthma
Asthma
0.700 GeneticVariation disease BEFREE Mice with a targeted deletion of the T-bet gene and severe combined immunodeficient mice receiving CD4+ cells from T-bet knockout mice spontaneously demonstrated multiple physiological and inflammatory features characteristic of asthma. 11786643 2002
CUI: C0004096
Disease: Asthma
Asthma
0.700 Biomarker disease HPO
CUI: C1319853
Disease: Asthma, Aspirin-Induced
Asthma, Aspirin-Induced
0.410 Biomarker disease CTD_human Several single nucleotide polymorphisms (SNPs) in the promoters of EP2, TBX21, COX-2, Fc epsilon RIbeta, and TBXA2R were associated with AIA, while an Fc epsilon RIalpha promoter polymorphism was associated with AIU. 16502481 2006